RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kyorin Pharmaceutical Co Stock

Kyorin Pharmaceutical Co Equity 2025

Kyorin Pharmaceutical Co Equity

130.74 B JPY

Ticker

4569.T

ISIN

JP3247090008

In 2025, Kyorin Pharmaceutical Co's equity was 130.74 B JPY, a 4.2% increase from the 125.46 B JPY equity in the previous year.

Kyorin Pharmaceutical Co Aktienanalyse

What does Kyorin Pharmaceutical Co do?

Kyorin Holdings Inc is a Japanese holding company that was founded in September 2007. However, the company's history dates back to 1947 when Kyorin Pharmaceutical Co., Ltd. was established. Kyorin Holdings is a diversified company that operates in various sectors and business areas. The company's main activities include the development, production, and marketing of pharmaceutical products, medical devices, and healthcare products. In the pharmaceutical sector, Kyorin has been active since its inception. The company offers a wide range of products for various conditions such as asthma, allergies, or diabetes. Additionally, Kyorin is dedicated to developing medications for rarer diseases such as Fabry disease or amyotrophic lateral sclerosis (ALS). Another important business area of Kyorin is medical devices and accessories. The company primarily focuses on devices for the diagnosis and treatment of respiratory diseases and allergies. This includes inhalers, peak flow meters, and allergy tests. Healthcare is another significant business area of Kyorin Holdings. The company offers products for maintaining and strengthening the immune system, such as dietary supplements and probiotics. Kyorin also provides cosmetic products made from plant-based ingredients. One of Kyorin's current projects is the development of peptide-based immunotherapies for cancer. The company has already achieved promising results in preclinical research and plans to continue clinical trials in the coming years. The corporate philosophy of Kyorin emphasizes the importance of research and development. The company invests a significant portion of its annual revenue in research and development and strives to find innovative solutions for disease treatment. Kyorin also values collaboration with other companies and research institutions. The company has formed partnerships with other pharmaceutical and medical technology companies to work together on the research and development of new products. Kyorin Holdings Inc is a company that focuses on the development and marketing of products that contribute to improving health and well-being. The company's various business areas allow it to target different audiences and meet the needs of patients and customers in various fields. With its long-standing experience in the pharmaceutical and medical technology sectors and its commitment to innovation and research, Kyorin remains an important player in healthcare and is dedicated to improving the quality of life for people worldwide. Kyorin Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Kyorin Pharmaceutical Co's Equity

Kyorin Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Kyorin Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Kyorin Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Kyorin Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Kyorin Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Kyorin Pharmaceutical Co stock

What is the equity of Kyorin Pharmaceutical Co this year?

Kyorin Pharmaceutical Co has equity of 130.74 B JPY this year.

What was the equity of Kyorin Pharmaceutical Co compared to the previous year?

The equity of Kyorin Pharmaceutical Co has increased/decreased by 4.2% increased compared to the previous year.

What impact does a high equity have on investors of Kyorin Pharmaceutical Co?

A high equity is advantageous for investors of Kyorin Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Kyorin Pharmaceutical Co?

A low equity can be a risk for investors of Kyorin Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Kyorin Pharmaceutical Co affect the company?

An increase in equity of Kyorin Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Kyorin Pharmaceutical Co affect the company?

A reduction in equity of Kyorin Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Kyorin Pharmaceutical Co?

Some factors that can affect the equity of Kyorin Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Kyorin Pharmaceutical Co so important for investors?

The equity of Kyorin Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Kyorin Pharmaceutical Co take to change the equity?

To change equity, Kyorin Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Kyorin Pharmaceutical Co pay?

Over the past 12 months, Kyorin Pharmaceutical Co paid a dividend of 52 JPY . This corresponds to a dividend yield of about 3.59 %. For the coming 12 months, Kyorin Pharmaceutical Co is expected to pay a dividend of 52.5 JPY.

What is the dividend yield of Kyorin Pharmaceutical Co?

The current dividend yield of Kyorin Pharmaceutical Co is 3.59 %.

When does Kyorin Pharmaceutical Co pay dividends?

Kyorin Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kyorin Pharmaceutical Co?

Kyorin Pharmaceutical Co paid dividends every year for the past 22 years.

What is the dividend of Kyorin Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 52.5 JPY are expected. This corresponds to a dividend yield of 3.62 %.

In which sector is Kyorin Pharmaceutical Co located?

Kyorin Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyorin Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyorin Pharmaceutical Co from 6/1/2025 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.

When did Kyorin Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2025.

What was the dividend of Kyorin Pharmaceutical Co in the year 2024?

In the year 2024, Kyorin Pharmaceutical Co distributed 52 JPY as dividends.

In which currency does Kyorin Pharmaceutical Co pay out the dividend?

The dividends of Kyorin Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kyorin Pharmaceutical Co

Our stock analysis for Kyorin Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyorin Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.